|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | ||||||||||||||||||||
| Trading - U.S. Treasury Bills | ||||||||||||||||||||
| Investments in equity securities (includes GAMCO stock with a fair value of $16,248 and $16,920, respectively) | ||||||||||||||||||||
| Investments in affiliated registered investment companies | ||||||||||||||||||||
| Investment, Affiliated Issuer | ||||||||||||||||||||
| Total investments in affiliated registered investment companies | ||||||||||||||||||||
| Investments in partnerships | ||||||||||||||||||||
| Receivable from brokers | ||||||||||||||||||||
| Receivable from brokers (cash held for real estate purchase) | ||||||||||||||||||||
| Investment advisory fees receivable | ||||||||||||||||||||
| Receivable and investment in note receivable from affiliates | ||||||||||||||||||||
| Receivable from affiliates | ||||||||||||||||||||
| Income taxes receivable, including deferred tax assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Investments in marketable securities held in trust | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND EQUITY | ||||||||||||||||||||
| Payable to brokers | ||||||||||||||||||||
| Income taxes payable, including deferred tax liabilities, net | ||||||||||||||||||||
| Compensation payable | ||||||||||||||||||||
| Securities sold, not yet purchased | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Tendered redeemable noncontrolling interests payable | ||||||||||||||||||||
| Deferred underwriting fee payable | ||||||||||||||||||||
| PMV warrant liability | ||||||||||||||||||||
| Dividend payable | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Redeemable noncontrolling interests | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Preferred stock, $0.001 par value; 10,000,000 shares authorized; none issued and outstanding | ||||||||||||||||||||
| Common Stock | ||||||||||||||||||||
| Common Class A | ||||||||||||||||||||
| Common Class B | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Treasury stock, at cost (3,654,184 and 3,601,877 shares, respectively) | ||||||||||||||||||||
| Treasury stock, at cost (4,467,940 and 4,407,681 shares, respectively) | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total liabilities, redeemable noncontrolling interests and equity | ||||||||||||||||||||
Loading...